Reinforced absorbable multilayered hemostatis wound dressing

US9439997B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9439997-B2
Application numberUS-40084906-A
CountryUS
Kind codeB2
Filing dateApr 10, 2006
Priority dateOct 20, 2004
Publication dateSep 13, 2016
Grant dateSep 13, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is directed to a reinforced absorbable multilayered hemostatic wound dressing comprising a first absorbable nonwoven fabric, a second absorbable woven or knitted fabric, thrombin and/or fibrinogen.

First claim

Opening claim text (preview).

We claim: 1. A hemostatic multilayered wound dressing comprising a first carrier layer with thrombin and fibrinogen, each is in the form as a dispersed powder, wherein the first carrier layer is an absorbable nonwoven fabric having a basis weight of about 0.01 to 0.2 g/in 2 that comprises glycolide/lactide copolymer and a staple fiber having a length from about 1.0 to 1.3 inches that is derived from fiber of about 1 to 4 denier per filament, and one or more second absorbable woven or knitted fabric having a basis weight of about 0.001 to 0.2 g/in 2 that comprises oxidized regenerated cellulose that reinforces the first carrier layer and is separate from the dispersed powders, wherein the multilayered dressing has a basis weight of about 0.1 to 1.0 g/in 2 , wherein the first absorbable nonwoven fabric comprises from about 70 to 95% by molar basis of polyglycolide and the remainder polylactide. 2. The multilayered dressing of claim 1 , where the staple fiber is crimped. 3. The multilayered dressing of claim 1 , wherein the thrombin activity on the multilayered dressing ranges from about 20 to 500 IU/cm 2 , and the fibrinogen amount on the multilayered dressing ranges from about 2 to 15 mg/cm 2 . 4. A hemostatic multilayered dressing comprising a first carrier layer with thrombin and fibrinogen, each is in the form as a dispersed powder, wherein the first carrier layer is an absorbable nonwoven fabric comprising glycolide/lactide copolymer and a staple fiber having a length from about 0.75 to 1.5 inch, a second absorbable woven or knitted fabric that is a reinforcing layer attached to the first carrier layer and is separate from the dispersed powders comprising oxidized regenerated cellulose, wherein the glycolide/lactide copolymer comprises from about 70 to 95% by molar basis of polyglycolide and the reminder polylactide, the thrombin activity on the multilayered dressing ranges from about 20 to 500 IU/cm 2 , the fibrinogen amount on the multilayered dressing ranges from about 2 to 15 mg/cm 2 . 5. The multilayered wound dressing according to claim 3 , wherein the dressing is sterilized. 6. The multilayered wound dressing according to claim 4 , wherein the dressing is sterilized. 7. A hemostatic multilayered wound dressing comprising a first absorbable nonwoven fabric and thrombin and fibrinogen as dispersed powders; one or more second absorbable woven or knitted fabric that comprises oxidized regenerated cellulose. 8. A hemostatic multilayered wound dressing as set forth in claim 1 or 4 wherein the fibrinogen amount is between 5-10 mg/cm 2 . 9. A hemostatic multilayered wound dressing as set forth in claim 1 or 4 wherein the weight ratio of the fibrinogen to the carrier and reinforcing layers is in the range of 0.26:1 to 0.52:1.

Assignees

Inventors

Classifications

  • Vegetal fibres · CPC title

  • Cellulose fibres, e.g. cotton · CPC title

  • having two or more layers · CPC title

  • Materials for stopping bleeding · CPC title

  • Coating or impregnation functions biologically [e.g., insect repellent, antiseptic, insecticide, bactericide, etc.] · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9439997B2 cover?
The present invention is directed to a reinforced absorbable multilayered hemostatic wound dressing comprising a first absorbable nonwoven fabric, a second absorbable woven or knitted fabric, thrombin and/or fibrinogen.
Who is the assignee on this patent?
Gorman Anne Jessica, Pendharkar Sanyog Manohar, Zhang Guanghui, and 5 more
What technology area does this patent fall under?
Primary CPC classification A61L15/26. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).